Implementing precision medicine in endoscopy practice.
Endoscopy
Gastroenterology
Precision medicine
Journal
Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
revised:
17
06
2022
received:
30
04
2022
accepted:
28
06
2022
pubmed:
3
7
2022
medline:
6
8
2022
entrez:
2
7
2022
Statut:
ppublish
Résumé
In contrast to the "one-size-fits-all" approach, precision medicine focuses on providing health care tailored to individual variabilities. Implementing precision medicine in endoscopy practice involves selecting the appropriate procedures among the endoscopic armamentarium in the diagnosis and management of patients in a logical sequence, jointly considering the pretest probabilities of possible diagnoses, patients' comorbidities and preference, and risk-benefit ratio of the individual procedures given the clinical scenario. The aim of this review is to summarize evidence-supported strategies and measures that may enhance precision medicine in general endoscopy practice.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1455-1468Informations de copyright
© 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Prewitt K, Schwandt TA, Straf ML et al. Using Science as Evidence in Public Policy. Washington, DC: National Academies Press, 2012.
He Z, Liu Z, Liu M et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut 2019; 68: 198-206.
Chen CH, Wang WL, Hsu MH, Mochly-Rosen D. Alcohol consumption, ALDH2 polymorphism as risk factors for upper aerodigestive tract cancer progression and prognosis. Life (Basel) 2022; 12.
Yokoyama A, Kumagai Y, Yokoyama T et al. Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 651-655.
Wang WL, Lee CT, Lee YC et al. Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck 2011; 33: 77-81.
Lee YC, Wang CP, Chen CC et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest. Endosc. 2009; 69: 408-417.
Su YY, Chen WC, Chuang HC et al. Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngol. Head Neck Surg. 2013; 139: 350-354.
Wang CH, Lee YC, Wang CP et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety. Dig. Endosc. 2014; 26: 24-31.
Morita FH, Bernardo WM, Ide E et al. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. BMC Cancer 2017; 17: 54.
Pimentel-Nunes P, Pioche M, Albéniz E et al. Curriculum for endoscopic submucosal dissection training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 2019; 51: 980-992.
Ishihara R, Arima M, Iizuka T et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig. Endosc. 2020; 32: 452-493.
Ishihara R, Iishi H, Takeuchi Y et al. Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest. Endosc. 2008; 67: 799-804.
Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002; 94: 570-575.
Eguchi T, Nakanishi Y, Shimoda T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod. Pathol. 2006; 19: 475-480.
Koterazawa Y, Nakamura T, Oshikiri T et al. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg. Today 2018; 48: 783-789.
Kanie Y, Okamura A, Asari T et al. Additional treatment following noncurative endoscopic resection for esophageal squamous cell carcinoma: a comparison of outcomes between esophagectomy and chemoradiotherapy. Ann. Surg. Oncol. 2021; 28: 8428-8435.
Oliveira JF, Moura EG, Bernardo WM et al. Prevention of esophageal stricture after endoscopic submucosal dissection: a systematic review and meta-analysis. Surg. Endosc. 2016; 30: 2779-2791.
Kagemoto K, Urabe Y, Miwata T et al. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Cancer Med. 2016; 5: 1397-1404.
Katada C, Yokoyama T, Yano T et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology 2016; 151: 860-869 e7.
Amanuma Y, Horimatsu T, Ohashi S, Tamaoki M, Muto M. Association of local complete response with prognosis after salvage photodynamic therapy for esophageal squamous cell carcinoma. Dig. Endosc. 2020.
Matsutani T, Nomura T, Hagiwara N, Matsuda A, Uchida E. Salvage endoscopic argon plasma coagulation after chemoradiotherapy for inoperable esophageal cancer. Surg. Laparosc. Endosc. Percutan. Tech. 2017; 27: 384-390.
Bergman JJ, Zhang YM, He S et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest. Endosc. 2011; 74: 1181-1190.
He S, Bergman J, Zhang Y et al. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy 2015; 47: 398-408.
Chiu PWY, Uedo N, Singh R et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut 2019; 68: 186-197.
Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest. Endosc. 2016; 84: 18-28.
Lin JT. Screening of gastric cancer: who, when, and how. Clin. Gastroenterol. Hepatol. 2014; 12: 135-138.
Blair VR, McLeod M, Carneiro F et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020; 21: e386-e397.
Muto M, Yao K, Kaise M, Kato M, Uedo N, Yagi K, Tajiri H. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig. Endosc. 2016; 28: 379-393.
Gupta S, Li D, El Serag HB et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology 2020; 158: 693-702.
Hölscher AH, Drebber U, Mönig SP, Schulte C, Vallböhmer D, Bollschweiler E. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann. Surg. 2009; 250: 791-797.
Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer 2008; 11: 134-148.
Hirasawa T, Gotoda T, Miyata S et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009; 12: 148-152.
Park Y-M, Cho E, Kang H-Y, Kim JM. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg. Endosc. 2011; 25: 2666-2677.
Japanese Gastric Cancer A. Japanese Gastric Cancer Treatment Guidelines 2018, 5th edn, Vol. 24. Gastric Cancer, 2021; 1-21.
Jeon MY, Park JC, Hahn KY, Shin SK, Lee SK, Lee YC. Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment. Gastrointest. Endosc. 2018; 87: 1003-1013.e2.
Committee ASoP, Buxbaum JL, Abbas Fehmi SM et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest. Endosc. 2019; 89: 1075-1105 e15.
Manes G, Paspatis G, Aabakken L et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2019; 51: 472-491.
van der Gaag NA, Rauws EA, van Eijck CH et al. Preoperative biliary drainage for cancer of the head of the pancreas. N. Engl. J. Med. 2010; 362: 129-137.
El Chafic AH, Dewitt J, Leblanc JK et al. Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients. Endoscopy 2013; 45: 883-889.
Sadeghi A, Mohamadnejad M, Islami F, Keshtkar A, Biglari M, Malekzadeh R, Eloubeidi MA. Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest. Endosc. 2016; 83: 290-8 e1.
Gerges C, Beyna T, Tang RSY et al. Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video). Gastrointest. Endosc. 2020; 91: 1105-1113.
Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig. Dis. Sci. 2011; 56: 663-672.
Kennedy TJ, Yopp A, Qin Y et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 2009; 11: 445-451.
Qumseya BJ, Jamil LH, Elmunzer BJ et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest. Endosc. 2021; 94: 222-234 e22.
Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016; 2: 112-117.
Tringali A, Hassan C, Rota M, Rossi M, Mutignani M, Aabakken L. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy 2018; 50: 631-641.
Lee TH, Choi JH, do Park H et al. Similar efficacies of endoscopic ultrasound-guided transmural and percutaneous drainage for malignant distal biliary obstruction. Clin. Gastroenterol. Hepatol. 2016; 14: 1011-1019 e3.
Sharaiha RZ, Khan MA, Kamal F et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest. Endosc. 2017; 85: 904-914.
Vienne A, Hobeika E, Gouya H et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest. Endosc. 2010; 72: 728-735.
Dumonceau JM, Tringali A, Papanikolaou IS et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline-updated October 2017. Endoscopy 2018; 50: 910-930.
Moole H, Dharmapuri S, Duvvuri A et al. Endoscopic versus percutaneous biliary drainage in palliation of advanced malignant hilar obstruction: a meta-analysis and systematic review. Can. J. Gastroenterol. Hepatol. 2016; 2016: 4726078.
Sawas T, Al Halabi S, Parsi MA et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest. Endosc. 2015; 82: 256-267 e7.
Lee TH, Kim TH, Moon JH et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest. Endosc. 2017; 86: 817-827.
Kao D, Zepeda-Gomez S, Tandon P, Bain VG. Managing the post-liver transplantation anastomotic biliary stricture: multiple plastic versus metal stents: a systematic review. Gastrointest. Endosc. 2013; 77: 679-691.
Visconti TAC, Bernardo WM, Moura DTH et al. Metallic vs plastic stents to treat biliary stricture after liver transplantation: a systematic review and meta-analysis based on randomized trials. Endosc Int Open 2018; 6: E914-E923.
Ramchandani M, Lakhtakia S, Costamagna G et al. Fully covered self-expanding metal stent vs multiple plastic stents to treat benign biliary strictures secondary to chronic pancreatitis: a multicenter randomized trial. Gastroenterology 2021; 161: 185-195.
Committee ASoP, Jue TL, Storm AC et al. ASGE guideline on the role of endoscopy in the management of benign and malignant gastroduodenal obstruction. Gastrointest. Endosc. 2021; 93: 309-322 e4.
Yamao K, Kitano M, Takenaka M et al. Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan. Gastrointest. Endosc. 2018; 88: e2.
Pouw RE, Barret M, Biermann K et al. Endoscopic tissue sampling-part 1: upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2021; 53: 1174-1188.
Tiriac H, Bucobo JC, Tzimas D et al. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest. Endosc. 2018; 87: 1474-1480.
Vlachogiannis G, Hedayat S, Vatsiou A et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 2018; 359: 920-926.
Goggins M, Overbeek KA, Brand R et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020; 69: 7-17.
Tanaka M, Fernandez-Del Castillo C, Kamisawa T et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17: 738-753.
Vege SS, Ziring B, Jain R et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015; 148: 819-822 quize12-3.
European Study Group on Cystic Tumours of the P. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789-804.
Cahen DL, Gouma DJ, Nio Y et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N. Engl. J. Med. 2007; 356: 676-684.
Kitano M, Gress TM, Garg PK et al. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology 2020; 20: 1045-1055.
Alexakis N, Sutton R, Raraty M et al. Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality. Br. J. Surg. 2004; 91: 1020-1026.
Moole H, Jaeger A, Bechtold ML, Forcione D, Taneja D, Puli SR. Success of extracorporeal shock wave lithotripsy in chronic calcific pancreatitis management: a meta-analysis and systematic review. Pancreas 2016; 45: 651-658.
Song JH, Hong SN, Kyung Chang D et al. The etiology of potential small-bowel bleeding depending on patient's age and gender. United European Gastroenterol J 2018; 6: 1169-1178.
Matsumura T, Arai M, Saito K et al. Predictive factor of re-bleeding after negative capsule endoscopy for obscure gastrointestinal bleeding: over 1-year follow-up study. Dig. Endosc. 2014; 26: 650-658.
Estevinho MM, Pinho R, Fernandes C et al. Diagnostic and therapeutic yields of early capsule endoscopy and device-assisted enteroscopy in the setting of overt GI bleeding: a systematic review with meta-analysis. Gastrointest. Endosc. 2022; 95: 610-625 e9.
Uchida G, Nakamura M, Yamamura T et al. Systematic review and meta-analysis of the diagnostic and therapeutic yield of small bowel endoscopy in patients with overt small bowel bleeding. Dig. Endosc. 2021; 33: 66-82.
Kudo S-e, Sugihara Y, Kida H et al. Depressed-type colonic lesions and “de novo” cancer in familial adenomatous polyposis: a colonoscopist's viewpoint. ISRN. Gastroenterology 2013; 2013.
Soetikno R, Chiu HM, Asokkumar R et al. Use of the ACES (Appearance, Classification, Enhanced endoscopy, and Safe resection) algorithm for the recognition and management of malignant polyps-a letter in response to the Multi-Society Task Force on Colorectal Cancer recommendations. Gastrointest. Endosc. 2021; 93: 1194-1198.
Chiu HM, Lin JT, Chen CC et al. Prevalence and characteristics of nonpolypoid colorectal neoplasm in an asymptomatic and average-risk chinese population. Clin. Gastroenterol. Hepatol. 2009; 7: 463-470.
Bogie RMM, Veldman MHJ, Snijders LARS et al. Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis. Endoscopy 2018; 50: 263-282.
Yamada M, Saito Y, Sakamoto T, Nakajima T, Kushima R, Parra-Blanco A, Matsuda T. Endoscopic predictors of deep submucosal invasion in colorectal laterally spreading tumors. Endoscopy 2016; 48: 456-464.
Hayashi N, Tanaka S, Hewett DG et al. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest. Endosc. 2013; 78: 625-632.
Sano Y, Tanaka S, Kudo S-E et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 2016; 28: 526-533.
Matsuda T, Fujii T, Saito Y et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am. J. Gastroenterol. 2008; 103: 2700-2706.
Silva GLR, de Moura EGH, Bernardo WM, Leite de Castro V, Morais C, Baba ER, Safatle-Ribeiro AV. Endoscopic versus surgical resection for early colorectal cancer-a systematic review and meta-analysis. Journal of Gastrointestinal Oncology 2016; 7: 326-335.
Ikematsu H, Yoda Y, Matsuda T et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 2013; 144: 551-559.
Tanaka S, Kashida H, Saito Y et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig. Endosc. 2020; 32: 219-239.
Moss A, Williams SJ, Hourigan LF et al. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut 2015; 64: 57-65.
Bahin FF, Heitman SJ, Rasouli KN et al. Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis. Gut 2018; 67: 1965-1973.
Tziatzios G, Gkolfakis P, Triantafyllou K et al. Higher rate of en bloc resection with underwater than conventional endoscopic mucosal resection: a meta-analysis. Dig. Liver Dis. 2021; 53: 958-964.
Fahmawi Y, Hanjar A, Ahmed Y et al. Efficacy and safety of full-thickness resection device (FTRD) for colorectal lesions endoscopic full-thickness resection: a systematic review and meta-analysis. J. Clin. Gastroenterol. 2021; 55: e27-e36.
Atallah C, Taylor JP, Lo BD, Stem M, Brocke T, Efron JE, Safar B. Local excision for T1 rectal tumours: are we getting better? Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 2020; 22: 2038-2048.
Wang AY, Hwang JH, Bhatt A, Draganov PV. AGA clinical practice update on surveillance after pathologically curative endoscopic submucosal dissection of early gastrointestinal neoplasia in the United States: commentary. Gastroenterology 2021; 161: 2030-2040.e1.
Bosch SL, Teerenstra S, de Wilt JHW, Cunningham C, Nagtegaal ID. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 2013; 45: 827-834.
Backes Y, de Vos Tot Nederveen Cappel WH, van Bergeijk J et al. Risk for incomplete resection after macroscopic radical endoscopic resection of T1 colorectal cancer: a multicenter cohort study. Am. J. Gastroenterol. 2017; 112: 785-796.
Ozawa T, Kandimalla R, Gao F et al. A microRNA signature associated with metastasis of T1 colorectal cancers to lymph nodes. Gastroenterology 2018; 154: 844-848. e7.
Quintero E, Castells A, Bujanda L et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. New England Journal of Medicine 2012; 366: 697-706.
Chiu HM, Chen SLS, Yen AMF et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015; 121: 3221-3229.
Zorzi M, Fedeli U, Schievano E et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2015; 64: 784-790.
Moss S, Mathews C, Day T, Smith S, Seaman HE, Snowball J, Halloran SP. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut 2017; 66: 1631-1644.
Wong MC, Ching JY, Chan VC et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin. Gastroenterol. Hepatol. 2015; 13: 1472-1479.
Chiu HM, Lee YC, Tu CH et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin. Gastroenterol. Hepatol. 2013; 11: 832-838. e2.
Lee JK, Liles EG, Bent S et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann. Intern. Med. 2014; 160: 171-181.
Chang L-C, Shun C-T, Hsu W-F et al. Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity. Clin. Gastroenterol. Hepatol. 2017; 15: 872-879. e1.
Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Multitarget stool DNA testing for colorectal-cancer screening. New England Journal of Medicine 2014; 370: 1287-1297.
Liang JQ, Li T, Nakatsu G et al. A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer. Gut 2020; 69: 1248-1257.
Wong SH, Kwong TN, Chow T-C et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 2017; 66: 1441-1448.
Knudsen AB, Zauber AG, Rutter CM et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA 2016; 315: 2595-2609.
Yeoh K-G, Ho K-Y, Chiu H-M et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011; 60: 1236-1241.
Hsu W-F, Hsu C-Y, Chen H-H. Future of Colorectal Cancer Screening: Screening in the Big Data Era and Personalized Screening Strategy, Colorectal Cancer Screening. Springer, 2021; 135-145.
Dixon P, Keeney E, Taylor JC, Wordsworth S, Martin RM. Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review. Genet. Med. 2022.
Van Hees F, Saini SD, Lansdorp-Vogelaar I et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology 2015; 149: 1425-1437.
Lansdorp-Vogelaar I, Gulati R, Mariotto AB et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann. Intern. Med. 2014; 161: 104-112.
Hassan C, Antonelli G, Dumonceau J-M et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline-update 2020. Endoscopy 2020; 52: 687-700.
Gupta S, Lieberman D, Anderson JC et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2020; 158: 1131-1153.e5.
Nishihara R, Wu K, Lochhead P et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095-1105.
Lee JK, Jensen CD, Levin TR et al. Long-term risk of colorectal cancer and related deaths after a colonoscopy with normal findings. JAMA Intern. Med. 2019; 179: 153-160.
Wieszczy P, Kaminski MF, Franczyk R et al. Colorectal cancer incidence and mortality after removal of adenomas during screening colonoscopies. Gastroenterology 2020; 158: 875-883.e5.
Park S-K, Hwang SW, Kim KO et al. Risk of advanced colorectal neoplasm in patients with more than 10 adenomas on index colonoscopy: a Korean Association for the Study of Intestinal Diseases (KASID) study. J. Gastroenterol. Hepatol. 2017; 32: 803-808.
He X, Hang D, Wu K et al. Long-term risk of colorectal cancer after removal of conventional adenomas and serrated polyps. Gastroenterology 2020; 158: 852-861.e4.
Li D, Doherty AR, Raju M et al. Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps. Gut 2021: gutjnl-2021-324301.
Chiu SY-H, Chuang S-L, Chen SL-S et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut 2017; 66: 293-300.
Peng S-M, Hsu W-F, Wang Y-W et al. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Gut 2020: gutjnl-2020-320761.
Chiu H-M, Lee Y-C, Tu C-H et al. Effects of metabolic syndrome and findings from baseline colonoscopies on occurrence of colorectal neoplasms. Clin. Gastroenterol. Hepatol. 2015; 13: 1134-1142.e8.
Chang WY, Lin HH, Chang LC, Hsu WF, Wu MS, Chiu HM. Active exercise after polypectomy reduces the risk of metachronous advanced colorectal neoplasm. Dig. Endosc. 2021: den.14127.
Kastrinos F, Samadder NJ, Burt RW. Use of family history and genetic testing to determine risk of colorectal cancer. Gastroenterology 2020; 158: 389-403.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 2015; 110: 223.
Khan Z, Khan MA, Hajifathalian K et al. Efficacy of endoscopic interventions for the management of obesity: a meta-analysis to compare endoscopic sleeve gastroplasty, aspireassist, and primary obesity surgery endolumenal. Obes. Surg. 2019; 29: 2287-2298.
Sharaiha RZ, Hajifathalian K, Kumar R et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin. Gastroenterol. Hepatol. 2021; 19: 1051-1057 e2.
Li R, Veltzke-Schlieker W, Adler A et al. Endoscopic sleeve gastroplasty (ESG) for high-risk patients, high body mass index (> 50 kg/m2) patients, and contraindication to abdominal surgery. Obes. Surg. 2021; 31: 3400-3409.
Singh S, de Moura DTH, Khan A et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes. Surg. 2020; 30: 3010-3029.
clinicaltrials.gov. ENDObesity II Study: TransPyloric Shuttle system for weight loss-study results- ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/results/NCT02518685).
Lopez-Nava G, Jaruvongvanich V, Storm AC et al. Personalization of endoscopic bariatric and metabolic therapies based on physiology: a prospective feasibility study with a single fluid-filled intragastric balloon. Obes. Surg. 2020; 30: 3347-3353.